Rp-cAMPS

CAT:
804-HY-100530A
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Rp-cAMPS - image 1

Rp-cAMPS

  • Description:

    Rp-cAMPS, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 μM and 4.5 μM, respectively) antagonist. Rp-cAMPS is resistant to hydrolysis by phosphodiesterases[1][2][3][4][5][6].
  • UNSPSC:

    12352005
  • Target:

    PKA
  • Type:

    Reference compound
  • Related Pathways:

    Stem Cell/Wnt; TGF-beta/Smad
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/rp-camps.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O[C@H]1[C@@H] (O[C@@]2 ([H]) [C@@]1 ([H]) O[P@@] (OC2) (S) =O) N3C4=C (C (N) =NC=N4) N=C3
  • Molecular Formula:

    C10H12N5O5PS
  • Molecular Weight:

    345.27
  • References & Citations:

    [1] Rothermel JD, et al. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'- (cyclic) phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J. 1988 May 1;251 (3) :757-62.|[2]Fu Y, et al. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain. 2008 Jul 16;4:26.|[3]Kuriyama S, et al. Isoproterenol inhibits rod outer segment phagocytosis by both cAMP-dependent and independent pathways. Invest Ophthalmol Vis Sci. 1995 Mar;36 (3) :730-6.|[4]Dostmann WR, et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem. 1990 Jun 25;265 (18) :10484-91.|[5]Van Haastert PJ, et al. Competitive cAMP antagonists for cAMP-receptor proteins. J Biol Chem. 1984 Aug 25;259 (16) :10020-4.|[6]R J de Wit, et al. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur J Biochem. 1984 Jul 16;142 (2) :255-60.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Citation 01:

    Theranostics. 2021 Mar 24;11 (12) :5650-5674.|Cell Commun Signal. 2024 Jun 3;22 (1) :307.|Nat Commun. 2025 Jul 1;16 (1) :5425.|Research Square Preprint. 2024 Apr 9.
  • CAS Number:

    73208-40-9